Pharmaceuticals Insights

abstract circuits demonstrating digitalization

Intro to pharma 4.0 and facility digitalization

Creating a roadmap to the digitalization of your next pharmaceutical facility.

Large-scale oligo synthesis: Scaling-up requirements

New uses for oligonucleotides and increasing demand are driving oligo manufacturers to scale up to commercial production.

The current state of aseptic processing & fill-finish manufacturing

Providing patients with contaminant-free drug products that are as effective and safe as possible is the core demand of the fill-finish process.

How to maintain low temperatures in your plasma fractionation process

Keeping your plasma fractionation process and facility cold requires careful planning and design.

DNA strand used in oligonucleotide manufacturing

Best practices in oligonucleotide manufacturing

After decades of research, the oligonucleotide industry has reached a tipping point and is experiencing a huge surge of interest and momentum.

Plasma facility delivery: 3 reasons to choose IPD

When it comes to highly complex plasma fractionation facilities, integrated project delivery is an optimal way to design and build.

5 current trends that will shape the life sciences in 2021 and beyond

Many of the life sciences trends that are driving innovation today were here pre-COVID, but the pandemic was an accelerant. For all that it took, it gave life science researchers and developers new momentum, and from that momentum, hope.

Considerations for scaling your oligo manufacturing facility

5 questions to ask when designing oligonucleotide facilities

As industry momentum continues, oligonucleotide manufacturers are making the leap from benchtop production to commercial scale. The challenges of large-scale oligo manufacturing, however, are exponential in comparison to small scale, lab-based operations.